CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer - ScienceDirect
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2 | Nature Communications
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity | Journal for ImmunoTherapy of Cancer
dc_2020_22
The Use of Post-attachment Inhibitors for HIV Treatment
Uptake és efflux transzporterekkel kölcsönható vegyületek azonosítása robotizált platformon
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | PNAS